Elie G. Gharib

Cardiology

430 Main St W
Oak Hill,, WV 25901

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Orthostatic Hypertensive Emergency in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Single-Center Retrospective Observational Study.

Orthostatic Hypertensive Emergency in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Single-Center Retrospective Observational Study.

Journal: Cureus

Published: June 25, 2026

Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial.

Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial.

Journal: Journal of the American College of Cardiology

Published: December 09, 2025

"Evaluating the efficacy and safety of direct oral anticoagulants compared to warfarin in very morbidly obese patients with non-valvular atrial fibrillation: A retrospective cohort study".

"Evaluating the efficacy and safety of direct oral anticoagulants compared to warfarin in very morbidly obese patients with non-valvular atrial fibrillation: A retrospective cohort study".

Journal: Heliyon

Published: August 15, 2024

Effect of Nothing by Mouth (NPO) on Cases of Cardiac Catheterizations.

Effect of Nothing by Mouth (NPO) on Cases of Cardiac Catheterizations.

Journal: The American journal of cardiology

Published: October 10, 2022

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.

Journal: JACC. Cardiovascular interventions

Published: February 16, 2022

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.

Journal: JACC. Cardiovascular interventions

Published: December 04, 2019

Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women.

Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women.

Journal: Circulation. Cardiovascular interventions

Published: April 19, 2019

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.

Journal: Circulation. Cardiovascular interventions

Published: October 26, 2018

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

Journal: Journal of the American College of Cardiology

Published: September 09, 2018

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

Journal: Lancet (London, England)

Published: July 19, 2017

Advances in the management of hyperkalemia in chronic kidney disease.

Advances in the management of hyperkalemia in chronic kidney disease.

Journal: Current opinion in nephrology and hypertension

Published: February 18, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026